Cohort effects in dynamic models and their impact on vaccination programmes: An example from Hepatitis A

Arni S.R. Srinivasa Rao, Maggie H. Chen, Ba'Z Pham, Andrea C. Tricco, Vladimir Gilca, Bernard Duval, Murray D. Krahn, Chris T. Bauch

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Infection rates for many infectious diseases have declined over the past century. This has created a cohort effect, whereby older individuals experienced a higher infection rate in their past than younger individuals do now. As a result, age-stratified seroprevalence profiles often differ from what would be expected from constant infection rates. Methods: Here, we account for the cohort effect by fitting an age-structured compartmental model with declining transmission rates to Hepatitis A seroprevalence data for Canadian-born individuals. We compare the predicted impact of universal vaccination with and without including the cohort effect in the dynamic model. Results: We find that Hepatitis A transmissibility has declined by a factor of 2.8 since the early twentieth century. When the cohort effect is not included in the model, incidence and mortality both with and without vaccination are significantly over-predicted. Incidence (respectively mortality) over a 20 year period of universal vaccination is 34% (respectively 90%) higher than if the cohort effect is included. The percentage reduction in incidence and mortality due to vaccination are also over-predicted when the cohort effect is not included. Similar effects are likely for many other infectious diseases where infection rates have declined significantly over past decades and where immunity is lifelong. Conclusion: Failure to account for cohort effects has implications for interpreting seroprevalence data and predicting the impact of vaccination programmes with dynamic models. Cohort effects should be included in dynamic modelling studies whenever applicable.

Original languageEnglish (US)
Article number174
JournalBMC Infectious Diseases
Volume6
DOIs
StatePublished - Dec 5 2006

Fingerprint

Cohort Effect
Hepatitis A
Vaccination
Seroepidemiologic Studies
Infection
Communicable Diseases
Mortality
Incidence
Immunity

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Cohort effects in dynamic models and their impact on vaccination programmes : An example from Hepatitis A. / Srinivasa Rao, Arni S.R.; Chen, Maggie H.; Pham, Ba'Z; Tricco, Andrea C.; Gilca, Vladimir; Duval, Bernard; Krahn, Murray D.; Bauch, Chris T.

In: BMC Infectious Diseases, Vol. 6, 174, 05.12.2006.

Research output: Contribution to journalArticle

Srinivasa Rao, Arni S.R. ; Chen, Maggie H. ; Pham, Ba'Z ; Tricco, Andrea C. ; Gilca, Vladimir ; Duval, Bernard ; Krahn, Murray D. ; Bauch, Chris T. / Cohort effects in dynamic models and their impact on vaccination programmes : An example from Hepatitis A. In: BMC Infectious Diseases. 2006 ; Vol. 6.
@article{87fcab949af9492592ac256c5bc22352,
title = "Cohort effects in dynamic models and their impact on vaccination programmes: An example from Hepatitis A",
abstract = "Background: Infection rates for many infectious diseases have declined over the past century. This has created a cohort effect, whereby older individuals experienced a higher infection rate in their past than younger individuals do now. As a result, age-stratified seroprevalence profiles often differ from what would be expected from constant infection rates. Methods: Here, we account for the cohort effect by fitting an age-structured compartmental model with declining transmission rates to Hepatitis A seroprevalence data for Canadian-born individuals. We compare the predicted impact of universal vaccination with and without including the cohort effect in the dynamic model. Results: We find that Hepatitis A transmissibility has declined by a factor of 2.8 since the early twentieth century. When the cohort effect is not included in the model, incidence and mortality both with and without vaccination are significantly over-predicted. Incidence (respectively mortality) over a 20 year period of universal vaccination is 34{\%} (respectively 90{\%}) higher than if the cohort effect is included. The percentage reduction in incidence and mortality due to vaccination are also over-predicted when the cohort effect is not included. Similar effects are likely for many other infectious diseases where infection rates have declined significantly over past decades and where immunity is lifelong. Conclusion: Failure to account for cohort effects has implications for interpreting seroprevalence data and predicting the impact of vaccination programmes with dynamic models. Cohort effects should be included in dynamic modelling studies whenever applicable.",
author = "{Srinivasa Rao}, {Arni S.R.} and Chen, {Maggie H.} and Ba'Z Pham and Tricco, {Andrea C.} and Vladimir Gilca and Bernard Duval and Krahn, {Murray D.} and Bauch, {Chris T.}",
year = "2006",
month = "12",
day = "5",
doi = "10.1186/1471-2334-6-174",
language = "English (US)",
volume = "6",
journal = "BMC Infectious Diseases",
issn = "1471-2334",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Cohort effects in dynamic models and their impact on vaccination programmes

T2 - An example from Hepatitis A

AU - Srinivasa Rao, Arni S.R.

AU - Chen, Maggie H.

AU - Pham, Ba'Z

AU - Tricco, Andrea C.

AU - Gilca, Vladimir

AU - Duval, Bernard

AU - Krahn, Murray D.

AU - Bauch, Chris T.

PY - 2006/12/5

Y1 - 2006/12/5

N2 - Background: Infection rates for many infectious diseases have declined over the past century. This has created a cohort effect, whereby older individuals experienced a higher infection rate in their past than younger individuals do now. As a result, age-stratified seroprevalence profiles often differ from what would be expected from constant infection rates. Methods: Here, we account for the cohort effect by fitting an age-structured compartmental model with declining transmission rates to Hepatitis A seroprevalence data for Canadian-born individuals. We compare the predicted impact of universal vaccination with and without including the cohort effect in the dynamic model. Results: We find that Hepatitis A transmissibility has declined by a factor of 2.8 since the early twentieth century. When the cohort effect is not included in the model, incidence and mortality both with and without vaccination are significantly over-predicted. Incidence (respectively mortality) over a 20 year period of universal vaccination is 34% (respectively 90%) higher than if the cohort effect is included. The percentage reduction in incidence and mortality due to vaccination are also over-predicted when the cohort effect is not included. Similar effects are likely for many other infectious diseases where infection rates have declined significantly over past decades and where immunity is lifelong. Conclusion: Failure to account for cohort effects has implications for interpreting seroprevalence data and predicting the impact of vaccination programmes with dynamic models. Cohort effects should be included in dynamic modelling studies whenever applicable.

AB - Background: Infection rates for many infectious diseases have declined over the past century. This has created a cohort effect, whereby older individuals experienced a higher infection rate in their past than younger individuals do now. As a result, age-stratified seroprevalence profiles often differ from what would be expected from constant infection rates. Methods: Here, we account for the cohort effect by fitting an age-structured compartmental model with declining transmission rates to Hepatitis A seroprevalence data for Canadian-born individuals. We compare the predicted impact of universal vaccination with and without including the cohort effect in the dynamic model. Results: We find that Hepatitis A transmissibility has declined by a factor of 2.8 since the early twentieth century. When the cohort effect is not included in the model, incidence and mortality both with and without vaccination are significantly over-predicted. Incidence (respectively mortality) over a 20 year period of universal vaccination is 34% (respectively 90%) higher than if the cohort effect is included. The percentage reduction in incidence and mortality due to vaccination are also over-predicted when the cohort effect is not included. Similar effects are likely for many other infectious diseases where infection rates have declined significantly over past decades and where immunity is lifelong. Conclusion: Failure to account for cohort effects has implications for interpreting seroprevalence data and predicting the impact of vaccination programmes with dynamic models. Cohort effects should be included in dynamic modelling studies whenever applicable.

UR - http://www.scopus.com/inward/record.url?scp=33845775261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845775261&partnerID=8YFLogxK

U2 - 10.1186/1471-2334-6-174

DO - 10.1186/1471-2334-6-174

M3 - Article

C2 - 17147828

AN - SCOPUS:33845775261

VL - 6

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

M1 - 174

ER -